Several studies suggest that ATF2 may function as an oncogene, worsening the outcome of the disease, as it increases the transcription of genes such as MMP2, MMP13, cyclin A, and aromatase that contribute to the progression and metastasis of breast cancer. This evidence concerns the gene MMP2 and breast cancer.